Cargando…
The Promise and the Reality of Stem-Cell Therapies for Neurodegenerative Diseases
Jonathan D. Glass, M.D., is leading a clinical trial testing the safety of using adult stem cells to treat patients with amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that remains untreatable. This trial, along with others like it, is just the beginning of a time-intensive process...
Autor principal: | Glass, Jonathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Dana Foundation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574778/ https://www.ncbi.nlm.nih.gov/pubmed/23447769 |
Ejemplares similares
-
Commentary on “The Promise and the Reality of Stem-Cell Therapies for Neurodegenerative Diseases”
por: Koliatsos, Vassilis E., et al.
Publicado: (2010) -
Promising Opportunities for Treating Neurodegenerative Diseases with Mesenchymal Stem Cell-Derived Exosomes
por: Guy, Reut, et al.
Publicado: (2020) -
Hydrogel-Based Nanocomposites and Mesenchymal Stem Cells: A Promising Synergistic Strategy for Neurodegenerative Disorders Therapy
por: Albani, Diego, et al.
Publicado: (2013) -
Nanotherapeutic and Stem Cell Therapeutic Strategies in Neurodegenerative Diseases: A Promising Therapeutic Approach
por: Wei, Min, et al.
Publicado: (2023) -
Promising Molecular Targets for Pharmacological Therapy of Neurodegenerative Pathologies
por: Neganova, M. E., et al.
Publicado: (2020)